Jul 09, 2009
Below is an exerpt from a direct to consumer advertisement on clopidogrel----
If you have been diagnosed with P.A.D., you need to learn how to lower your risk of heart attack or stroke. Individuals with P.A.D. have more than double the risk of heart attack or stroke compared to people who don't have P.A.D. Now is the time to explore all your treatment options to help reduce that risk, including P.A.D. medications like Plavix® (clopidogrel bisulfate).
PLAVIX is the only antiplatelet therapy FDA-approved for patients with established P.A.D. to help reduce the risk of heart attack and stroke. Medical guidelines recommend antiplatelet therapy, like PLAVIX, in addition to other risk-reducing medications for P.A.D. patients. Together, you and your doctor can design a plan that's right for you and may include P.A.D. medication, diet and exercise.
PLAVIX is prescribed to lower the risk of future heart attack or stroke in patients with established Peripheral Artery Disease.
I frequently have patients on fixed incomes that ask me if they should be on plavix because they have seen a commercial, print advertisement or direct mail. The company has done a great job of convincing people that if they are not on plavix, they should be. There is no doubt that plavix is a good medication and is essential in some patients. However, there are some patients who would best be served by a single aspirin per day at several cents per tablet as opposed to clopidogrel/plavix at $1-2 per pill. Another example of pharmaceuticals fleecing of America